Current screening methodologies in drug discovery for selected human diseases

OM Lage, MC Ramos, R Calisto, E Almeida… - Marine drugs, 2018 - mdpi.com
The increase of many deadly diseases like infections by multidrug-resistant bacteria implies
re-inventing the wheel on drug discovery. A better comprehension of the metabolisms and …

Cell-based assays: fuelling drug discovery

E Michelini, L Cevenini, L Mezzanotte, A Coppa… - Analytical and …, 2010 - Springer
It has been estimated that over a billion dollars in resources can be consumed to obtain
clinical approval, and only a few new chemical entities are approved by the US Food and …

In vitro cytotoxicity and cell viability assays: principles, advantages, and disadvantages

ÖS Aslantürk - Genotoxicity-A predictable risk to our actual world, 2018 - books.google.com
Cytotoxicity is one of the most important indicators for biological evaluation in vitro studies. In
vitro, chemicals such as drugs and pesticides have different cytotoxicity mechanisms such …

Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth

S Bruno, F Collino, MC Deregibus… - Stem cells and …, 2013 - liebertpub.com
Mesenchymal stem cells (MSCs) have opposite effects on tumor growth, being able either to
favor angiogenesis and tumor initiation or to inhibit progression of established tumors …

Human cytomegalovirus microRNA miR-US4-1 inhibits CD8+ T cell responses by targeting the aminopeptidase ERAP1

S Kim, S Lee, J Shin, Y Kim, I Evnouchidou, D Kim… - Nature …, 2011 - nature.com
Major histocompatibility complex (MHC) class I molecules present peptides on the cell
surface to CD8+ T cells, which is critical for the killing of virus-infected or transformed cells …

Are existing standard methods suitable for the evaluation of nanomedicines: some case studies

S Gioria, F Caputo, P Urbán, CM Maguire… - …, 2018 - Taylor & Francis
The use of nanotechnology in medical products has been demonstrated at laboratory scale,
and many resulting nanomedicines are in the translational phase toward clinical …

Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer

M Hijaz, S Das, I Mert, A Gupta, Z Al-Wahab, C Tebbe… - BMC cancer, 2016 - Springer
Background Nanomedicine is a very promising field and nanomedical drugs have recently
been used as therapeutic agents against cancer. In a previous study, we showed that …

A real-time, bioluminescent annexin V assay for the assessment of apoptosis

K Kupcho, J Shultz, R Hurst, J Hartnett, W Zhou… - Apoptosis, 2019 - Springer
Apoptosis is an important and necessary cell death program which promotes homeostasis
and organismal survival. When dysregulated, however, it can lead to a myriad of pathologies …

Enhancing reproducibility in cancer drug screening: how do we move forward?

C Hatzis, PL Bedard, NJ Birkbak, AH Beck, HJWL Aerts… - Cancer research, 2014 - AACR
Large-scale pharmacogenomic high-throughput screening (HTS) studies hold great
potential for generating robust genomic predictors of drug response. Two recent large-scale …

Dithiocarbamates: challenges, control, and approaches to excellent yield, characterization, and their biological applications

AT Odularu, PA Ajibade - Bioinorganic Chemistry and …, 2019 - Wiley Online Library
Progresses made in previous researches on syntheses of dithiocarbamates led to increase
in further researches. This paper reviews concisely the challenges experienced during the …